Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

'Investigating multi-modality therapy with irradiation and vascular-targeted photodynamic therapy in pre-clinical prostate cancer'

Richard BryantRichard Bryant is Associate Professor of Urology in the Nuffield Department of Surgical Sciences. His current laboratory research is based in the Department of Oncology within the Oxford Cancer Centre, where his focus is investigating the potential benefit of multi-modality therapy for prostate cancer. He is an Honorary Consultant Urologist in the Department of Urology in Oxford, where his clinical practice focusses on care for men with prostate cancer, along with core urology surgery and emergency urology, and he is co-Lead Investigator of the TRANSLATE clinical trial.  

 

Chair: Professor Ashok Handa

All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend.